Racing to Update the Vaccines For Variants
Prognosis: Losing it - A podcast by Bloomberg
![](https://is3-ssl.mzstatic.com/image/thumb/Podcasts122/v4/dd/a7/e9/dda7e99c-9166-0034-d844-d042c6dde518/mza_16074951556051024359.jpg/300x300bb-75.jpg)
Just two months ago, the incredible performance of new vaccines from Moderna and Pfizer had people cheering for an imminent end to the pandemic. But an onslaught of fast-spreading and potentially dangerous mutations of the virus changed that. So now, even as pharma companies ramp up production in the early stages of a massive rollout, they are racing to retool their vaccine strategies. Robert Langreth reports that booster shots could give drugmakers a lucrative new revenue stream. See omnystudio.com/listener for privacy information.